Back to search
Ductal Breast Carcinoma In Situ
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Ductal Breast Carcinoma In Situ trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Ductal Breast Carcinoma In Situ trials you may qualify forThe goal of this trial is to see if active surveillance monitoring and hormonal therapy in patients diagnosed with ductal cell carcinoma in situ (DCIS), an earl…
This study investigates the impact of COVID-19 pandemic on out-of-pocket costs, lost wages, and unemployment in patients with breast cancer undergoing breast su…
This phase II trial evaluates response-guided low-dose tamoxifen for reducing breast density in women who are at higher than average risk for breast cancer. Inc…
The standard surgical approach for all patients undergoing mastectomy for the treatment of non-invasive, ductal carcinoma in situ (DCIS) is to perform axillary…
This phase II trial tests the effectiveness of cannabidiol (CBD) plant extract (BRC-001) in improving joint stiffness and pain (arthralgia) in women with breast…
This is a prospective, non-interventional (observational) cohort study conducted within the medical network of the participating investigators and institutions.…
This phase II trial tests how well fezolinetant works in improving vasomotor symptoms (VMS) in breast cancer patients taking endocrine therapy (ET). Anti-hormon…
This study will use an adjuvant radiation therapy regimen called APBI (accelerated partial breast irradiation). APBI is a treatment option available to women co…